Literature DB >> 11939704

Progress toward global eradication of poliomyelitis, 2001.

.   

Abstract

From the initiation of the global poliomyelitis eradication initiative in 1988 through 2001, the number of countries where polio is endemic decreased from 125 to 10, and the number of reported polio cases decreased by >99% from an estimated 350,000 to <1,000. Wild type 2 poliovirus has not been detected worldwide since October 1999. The American and Western Pacific Regions of the World Health Organization (WHO) have been certified free of indigenous wild poliovirus. Current challenges to global polio eradication efforts include ongoing intense transmission in northern India, continued importations of wild poliovirus into polio-free areas, and the detection of circulating vaccine-derived poliovirus (cVDPV). This report summarizes global progress in polio eradication during 2001 and the current status of the initiative.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11939704

Source DB:  PubMed          Journal:  MMWR Morb Mortal Wkly Rep        ISSN: 0149-2195            Impact factor:   17.586


  7 in total

Review 1.  Recent developments: Travel medicine.

Authors:  Jane N Zuckerman
Journal:  BMJ       Date:  2002-08-03

2.  Excretion of wild-type and vaccine-derived poliovirus in the feces of poliovirus receptor-transgenic mice.

Authors:  Hein J Boot; Daniella T J Kasteel; Anne-Marie Buisman; Tjeerd G Kimman
Journal:  J Virol       Date:  2003-06       Impact factor: 5.103

3.  Mechanism of action at the molecular level of the antiviral drug 3(2H)-isoflavene against type 2 poliovirus.

Authors:  Anna L Salvati; Alessandra De Dominicis; Sabrina Tait; Andrea Canitano; Armin Lahm; Lucia Fiore
Journal:  Antimicrob Agents Chemother       Date:  2004-06       Impact factor: 5.191

4.  Diagnosis and Management of Enteroviral Infections of the Central Nervous System.

Authors:  José R. Romero
Journal:  Curr Infect Dis Rep       Date:  2002-08       Impact factor: 3.663

5.  Equivalent schedules of intradermal fractional dose versus intramuscular full dose of inactivated polio vaccine for prevention of poliomyelitis.

Authors:  Nishant Jaiswal; Shreya Singh; Amit Agarwal; Anil Chauhan; Kiran K Thumburu; Harpreet Kaur; Meenu Singh
Journal:  Cochrane Database Syst Rev       Date:  2019-12-19

6.  Strategies for Improving Polio Surveillance Performance in the Security-Challenged Nigerian States of Adamawa, Borno, and Yobe During 2009-2014.

Authors:  Abdullahi Walla Hamisu; Ticha Muluh Johnson; Kehinde Craig; Pascal Mkanda; Richard Banda; Sisay G Tegegne; Ajiboye Oyetunji; Nuhu Ningi; Said M Mohammed; Mohammed Isa Adamu; Khalid Abdulrahim; Peter Nsubuga; Rui G Vaz; Ado J G Muhammed
Journal:  J Infect Dis       Date:  2015-12-10       Impact factor: 5.226

7.  Mandatory polio vaccination for travellers: protecting global public health.

Authors:  Paul D Rutter; Liam J Donaldson
Journal:  Lancet       Date:  2014-05-08       Impact factor: 79.321

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.